Chronic Hepatitis C, Genotype 1
Also known as: Genotype 1 chronic hepatitis C infection / Genotype 1 Chronic Hepatitis C / Chronic Hepatitis C Virus (HCV Infection Genotype 1) / Chronic Hepatitis C Genotype 1 / Chronic Hepatitis C, HCV Genotype 1 / Chronic Hepatitis C Virus (HCV) Infection Genotype 1 / Genotype 1 / Carrier of viral hepatitis C / Chronic hepatitis C (disorder) / Chronic viral hepatitis C / Hepatitis C, Chronic / Chronic hepatitis C
Drug | Drug Name | Drug Description |
---|---|---|
DB11586 | Asunaprevir | An NS3 protease inhibitor used to treat hepatitis C genotype 1b. |
DB08873 | Boceprevir | A hepatitis C virus NS3/4A protease inhibitor used in combination with other medications to treat chronic hepatitis C genotype 1 infection. Boceprevir is not indicated as monotherapy. |
DB09102 | Daclatasvir | A direct-acting antiviral agent used to treat specific hepatitis C virus (HCV) infections in combination with other antiviral agents. |
DB11574 | Elbasvir | An antiviral and NS5A inhibitor used to treat hepatitis C infections. |
DB13879 | Glecaprevir | A Hepatitis C NS3/4A protease inhibitor used to treat Hepatitis C. |
DB11575 | Grazoprevir | An antiviral and NS3/4A protease inhibitor used to treat hepatitis C infections. |
DB09027 | Ledipasvir | A direct-acting antiviral agent used to treat specific hepatitis C virus (HCV) infections in combination with other antiviral agents. |
DB13878 | Pibrentasvir | A Hepatitis C NS5A inhibitor used to treat Hepatitis C. |
DB06290 | Simeprevir | A direct-acting antiviral agent that inhibits HCV NS3/4A protease to treat chronic hepatitis C virus (HCV) infection in adults with HCV genotype 1 or 4. |
DB08934 | Sofosbuvir | A direct-acting antiviral agent used to treat specific hepatitis C virus (HCV) infections in combination with other antiviral agents. |
DB05521 | Telaprevir | An NS3/4A viral protease inhibitor used in combination with other antivirals for the curative treatment of chronic Hepatitis C Virus infections. |
DB11613 | Velpatasvir | A NS5A inhibitor used to treat chronic hepatitis C infections in patients without cirrhosis or with compensated cirrhosis. |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB11105 | Benzalkonium | 0 | Terminated | 1 |
DB06756 | Betaine | 0 | Terminated | 1 |
DB00008 | Peginterferon alfa-2a | 0 | Terminated | 1 |
DB00811 | Ribavirin | 0 | Terminated | 1 |
DB05258 | Interferon alfa | 1 / 2 | Completed | 1 |
DB00105 | Interferon alfa-2b | 1 / 2 | Completed | 1 |
DB00008 | Peginterferon alfa-2a | 1 / 2 | Completed | 1 |
DB05942 | GI-5005 | 2 | Completed | 1 |
DB14760 | Narlaprevir | 2 | Completed | 1 |
DB00008 | Peginterferon alfa-2a | 2 | Completed | 1 |
DB00811 | Ribavirin | 2 | Completed | 1 |
DB00503 | Ritonavir | 2 | Completed | 1 |
DB08934 | Sofosbuvir | 2 | Completed | 1 |
DB05665 | Boceprevir | 3 | Completed | 1 |
DB08873 | Boceprevir | 3 | Completed | 1 |
DB09183 | Dasabuvir | 3 | Completed | 3 |
DB05258 | Interferon alfa | 3 | Completed | 1 |
DB09296 | Ombitasvir | 3 | Completed | 3 |
DB09297 | Paritaprevir | 3 | Completed | 3 |
DB00008 | Peginterferon alfa-2a | 3 | Completed | 1 |
DB00022 | Peginterferon alfa-2b | 3 | Completed | 1 |
DB00811 | Ribavirin | 3 | Completed | 6 |
DB00503 | Ritonavir | 3 | Completed | 3 |
DB08934 | Sofosbuvir | 3 | Completed | 1 |
DB05521 | Telaprevir | 3 | Completed | 2 |
DB00008 | Peginterferon alfa-2a | 4 | Completed | 2 |
DB00811 | Ribavirin | 4 | Completed | 2 |
DB00022 | Peginterferon alfa-2b | Not Available | Completed | 1 |
DB00811 | Ribavirin | Not Available | Completed | 1 |